{
    "Trade/Device Name(s)": [
        "AssureTech Panel Dip Tests",
        "AssureTech Quick Cup Tests",
        "AssureTech Multi-drug Urine Test Panel",
        "AssureTech Multi-drug Urine Test Cup"
    ],
    "Submitter Information": "Assure Tech LLC",
    "510(k) Number": "K243996",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181768"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "QAW",
        "NFW",
        "QBF"
    ],
    "Summary Letter Date": "December 22, 2024",
    "Summary Letter Received Date": "December 26, 2024",
    "Submission Date": "December 22, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Methamphetamine Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Barbiturate Test System",
        "Methadone Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Propoxyphene Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Buprenorphine",
        "Oxazepam",
        "Cocaine",
        "Methadone metabolite",
        "Fentanyl",
        "Methylenedioxy-methamphetamine",
        "Methamphetamine",
        "Morphine",
        "Methadone",
        "Norfentanyl",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "Marijuana"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Panel Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunochromatographic assay",
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Immunochemistry"
    ],
    "Submission Type(s)": [
        "Panel",
        "Dip Card",
        "Cup",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech Panel Dip Tests, Quick Cup Tests, Multi-drug Urine Test Panel, and Multi-drug Urine Test Cup for rapid qualitative detection of drugs of abuse in human urine via lateral flow immunochromatographic assay",
    "Indications for Use Summary": "Qualitative and simultaneous detection of up to 17 drugs of abuse (including amphetamine, cocaine, marijuana, opiates, methamphetamine, fentanyl, norfentanyl, oxycodone, secobarbital, buprenorphine, methylenedioxy-methamphetamine, phencyclidine, methadone, EDDP, nortriptyline, propoxyphene, and adulterants) in human urine; for preliminary screening and in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}